Workflow
酶解植物蛋白饲料原料
icon
Search documents
美农生物(301156) - 上海美农生物科技股份有限公司投资者关系活动记录表20260129
2026-01-29 10:18
证券代码:301156 证券简称:美农生物 上海美农生物科技股份有限公司 投资者关系活动记录表 编号:2026-01 投资者关系 活动类别 特定对象调研 □媒体采访 □新闻发布会 现场参观 其他 分析师会议 业绩说明会 □路演活动 电话会议 参与单位名称 远希私募、绅徽投资、山西证券 时间 2026 年 1 月 29 日 地点 公司会议室 上市公司接待 人员姓名 董事会秘书:张维娓 投资者关系活动 主要内容介绍 本次活动主要交流内容如下: 一、董事会秘书简要介绍公司概况 二、互动交流问答环节: 1. 公司境内外业务占比情况如何?未来业务拓展计划是 什么? 答: 根据公司《2025 年半年度报告》披露的数据可以看出,公 司境内业务营业收入占比 60%多,境外业务营业收入占比接 近 40%。 未来,公司继续执行"深耕国内市场、突破国际市场"的 市场战略。在国内市场,将积极实施变革创新,通过拓宽 种类市场、做深客户市场、做强核心产品,发挥公司在国 内市场的客户资源、产品与服务能力、营销网络、品牌等 优势,继续做强做大。在海外市场,公司重点突破"一带 一路"沿线国家市场,坚持"走出去、请进来"的市场开 | 发策略,持 ...
美农生物分析师会议:调研日期-20250923
Dong Jian Yan Bao· 2025-09-23 13:11
Group 1: Report Basics - The report is about a research on Meinong Bio-tech, belonging to the agriculture, animal husbandry, feed, and fishery industry, with a research date of September 23, 2025 [1][16] - The listed company's reception staff includes the board secretary Zhang Weiwei and the head of the international marketing center, Hu Yanlingjun [16] Group 2: Research Institutions - The research institutions include securities companies such as Huatai Securities, Caitong Securities, Yuekai Securities, Huaxin Securities, and others like Hong Kong Dongjian International Securities, Xiaofeng Fund, and Fuzhijia Investment [17] - The proportion of securities companies among the research institutions is 46%, others 38%, law firms 8%, and investment companies 8% [20] Group 3: Core Views - The company adheres to the market strategy of "deeply cultivating the domestic market and breaking through the international market" and aims to become a globally leading animal nutrition technology company [23] - The company has a rich product line, a mature overseas dealer management model, and a set of core technologies, and it will continue to invest in international market development and new product R & D [23][27] Group 4: Company Business Analysis International Business - The company's international business has a first - mover advantage, with a sales network covering more than 40 countries and regions. It will continue to expand the international market through a two - pronged approach of "going out" and "digging deep" [23][25] - The overseas business income has maintained a growth rate of over 20% and accounts for nearly 40% of the total revenue. It adopts a sales model of "mainly distribution, supplemented by direct sales" [25] - The company has a mature overseas dealer management and selection model and manages exchange - rate risks through foreign exchange hedging [26] Core Technologies - The company has mastered core technologies such as formulation technology, preparation technology, and enzymatic hydrolysis technology, and continuously optimizes the process path design [27] Product Layout - The company's products include functional feed additives, nutritional feed additives, and enzymatic hydrolysis plant protein feed raw materials. It will launch corn - related products after the "100,000 - ton corn protein finishing project" is put into production [28][30] Talent Management - The company has built a "dual - wheel drive" talent management system of "internal self - cultivation and external talent introduction" and launched an equity incentive project and the "Meinong Academy" [30][31] Project Investment - The "100,000 - ton corn protein finishing project" is in line with national policies, which can improve the utilization rate of corn protein and create greater commercial value. Product prices will be determined by multiple factors [31][33][34]
美农生物(301156) - 上海美农生物科技股份有限公司投资者关系活动记录表20250923
2025-09-23 08:38
Group 1: Company Overview and Market Strategy - The company aims to become a global leader in animal nutrition technology, with a market strategy focused on "deepening domestic and breaking through internationally" [2] - The company has established a sales network covering over 40 countries and regions across Asia, Europe, Africa, South America, and Oceania, leveraging a distributor-centric model for international market expansion [3][4] - The company has maintained a growth rate of over 20% in its overseas business, with overseas revenue accounting for nearly 40% of total revenue [4] Group 2: International Market Expansion Initiatives - The company plans to focus on markets along the "Belt and Road" initiative, utilizing localized operations and technological innovation to build a competitive edge [3] - Key initiatives include developing new markets, deepening existing market value, and enhancing product lines based on customer needs [3] - The company emphasizes participation in international industry exhibitions to increase visibility and strengthen its international market image [3] Group 3: Financial Management and Risk Control - The company has developed a mature overseas distributor selection and management model over 20 years, focusing on credit policies and risk management [5] - It closely monitors macroeconomic conditions and adjusts sales strategies to mitigate risks, including currency risk through hedging [5] Group 4: Core Technologies and Product Development - The company has established a robust R&D system, focusing on core technologies such as formulation, preparation, and enzymatic technologies [6][7] - It aims to develop high-efficiency, safe, and environmentally friendly feed additives and enzymatic protein feed materials, with a focus on meeting diverse customer needs [8] - The upcoming "annual production of 100,000 tons of corn protein processing project" will introduce new products to alleviate domestic protein resource shortages [9][10] Group 5: Talent Management and Organizational Development - The company implements a dual-driven talent management system, focusing on internal development and external recruitment to support sustainable growth [8] - Initiatives include a stock incentive program and the establishment of "Meinong Academy" for comprehensive talent development [8]